Agalsidase beta 치료를 받은 여성 파브리병 환자의 심근병증 및 신장 기능: 치료 전과 치료 후 비교 분석
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis Wanner C, et al. ESC Heart Fail . 2020 Jun;7(3):825-834.
Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study Juan Pablo Torres, Denis Sauré, Marcel Goic, Charles Thraves, Jorge Pacheco, Javiera Burgos, Natalia Trigo, Felipe Del Solar, Ignasi Neira, Gonzalo Díaz, Miguel O’Ryan, Leonardo J Basso.
아갈시다제 베타 치료를 받은 파브리병 환자의 심장 및 뇌혈관 지표를 평가한 체계적 문헌 고찰 연구
A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase Beta Oudit GY, et al. Front Cardiovasc Med. 2025 Jan 21;11:1415547.
Trends in Proportions of Respiratory Syncytial Virus Infections Among Reported Respiratory Tract Infection Cases in Children Aged 0 to 5 Years in Western Pacific and Southeast Asia Regions: A Systematic Review and Meta-Analysis Sangshin Park, Hyezan Lee, Jung Yoon Park, Sujin Choi, Hyun Jung Kim, Lorenzo Bertizzolo, Young Hwa Lee, Young June Choe.
후기 발병형 폼페병 환자의 평가측정도구 개발 : Modified Rasch-Built Pompe-Specific Activity scale
Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale van Kooten HA, et al. Eur J Neurol. 2024:e16397